"# Page 1\n\n{\"primary_language\":\"en\",\"is_rotation_valid\":true,\"rotation_correction\":0,\"is_table\":false,\"is_diagram\":true,\"natural_text\":\"Sex at Birth: Male  \\nHeight: 178 cm  \\nAsthma: No  \\nEthnicity: Caucasian  \\nWeight: 111 kg  \\nBMI: 35  \\nCOPD: No  \\nSmoker: Yes; 10 Cigarette(s) per Day; Years Smoking 20; (10 Pack Years)  \\nComment: W. 111\\n\\nFVC (ex only)  \\nTest Date: 23/05/2025 15:59:33 PM  \\nInterpretation: GOLD(2008)/Hardie  \\nPost Time: 23/05/2025 2:17:02 PM  \\nBTPS (IN/EX): 1.10/1.02  \\nQuanjer (GLI), 2012\\n\\n| Parameter | Best | LLN | Z-Score | %Pred | Pred | Trial 5 | Trial 4 | Trial 2 | Best | Z-Score | %Pred | Chg | %Chg | Trial 2 | Trial 3 | Trial 1 |\\n|-----------|------|-----|---------|-------|------|---------|---------|---------|------|---------|-------|-----|------|---------|---------|---------|\\n| Time      |      |     |         |       |      |         |         |         |      |         |       |     |      |         |         |         |\\n| PM        | 2:04:53 | PM | 2:03:30 | PM | 2:01:15 | PM | 2:18:31 | PM | 2:19:22 | PM | 2:17:34 | PM |\\n| FVC [L]   | 2.74* | 3.98 | -3.52 | 54 | 5.07 | 2.72* | 2.74* | 2.63* | 2.81* | -3.42 | 55 | 0.07 | 2 | 2.81* | 2.79* | 2.69* |\\n| FEV1 [L]  | 1.39* | 3.14 | -4.99 | 35 | 4.01 | 1.39* | 1.36* | 1.36* | 1.61* | -4.56 | 40 | 0.22* | 16* | 1.61* | 1.52* | 1.57* |\\n| FEV1/FVC [%] | 50.7* | 60.6 | -4.38 | 64 | 79.4 | 51.1* | 49.5* | 51.9* | 57.4* | -3.36 | 72 | 6.7 | 13 | 57.4* | 54.6* | 58.3* |\\n| FEF25-75 [L/s] | 0.38* | 2.04 | -3.28 | 10 | 3.71 | 0.38* | 0.36* | 0.36* | 0.48* | -3.18 | 13 | 0.10 | 26 | 0.48* | 0.45* | 0.57* |\\n| PEF [L/s] | 5.18 | - | - | - | 5.18 | 5.02 | 4.38 | 6.25 | - | - | 1.08 | 21 | 6.11 | 6.25 | 5.69 |\\n| FET [s]   | 15.1 | - | - | - | 15.1 | 15.1 | 15.1 | 15.1 | - | - | 0.0 | 0 | 15.1 | 15.1 | 14.8 |\\n\\n* Indicates value outside normal range or significant post change.\\n\\nSession Quality  \\nPre FEV1 - A, FVC - A (FVC Var=0.021 (0.8%); FEV1 Var=0.03L (1.8%))  \\nPost FEV1 - A, FVC - A (FVC Var=0.021 (0.7%); FEV1 Var=0.04L (2.7%))\\n\\nSystem Interpretation  \\nPre Severe Obstruction  \\nPost Severe Obstruction\\n\\nOverall Syst. Interpret.  \\nSignificant pre - post change\\n\\nInline Filter  \\nEasyOne Filter SP\\n\\n---\\n\\nFlow [L/min] vs Volume [L]\\n\\nFEV1 in % of value at 25 years\\n\\n---\\n\\nVolume [L] vs Time [s]\"}\n\n---\n\n# Page 2\n\n{\"primary_language\":\"en\",\"is_rotation_valid\":true,\"rotation_correction\":0,\"is_table\":true,\"is_diagram\":false,\"natural_text\":\"| Sex at Birth | Male | Height | 178 cm | Asthma | No |\\n|-------------|------|--------|--------|--------|----|\\n| Ethnicity   | Caucasian | Weight | 111 kg | BMI | 35 |\\n\\n**XD 23/05/2025**\\n\\nSILICA MEDICAL\\n\\nA grade PRE bronchodilator -3 acceptable spirometry measurements with 2 best FEV1 repeatable within 0.150L.\\n\\nA grade PRE bronchodilator -3 acceptable spirometry measurements with 2 best FVC repeatable within 0.150L.\\n\\nSpirometry results demonstrate a ratio <LLN with an FEV1 as (50.7)% of predicted indicating a (severe) obstructive pattern.\\n\\nPOST bronchodilator spirometry performed following inhalation of 400ug salbutamol via spacer.\\n\\nA grade POST bronchodilator - 3 acceptable spirometry measurements with 2 best FEV1 repeatable within 0.150L.\\n\\nA grade POST bronchodilator - 3 acceptable spirometry measurements with 2 best FVC repeatable within 0.150L.\\n\\nPost bronchodilator results suggest a significant improvement in FEV1 of (16)% and (220) mLs.\"}"